During the 2016 Presidential campaign, then-candidate Donald Trump railed against Big Pharma for keeping drug prices artificially high. Last month, in his State of the Union address, President Trump said that he wants his administration “to make fixing the injustice of high drug prices one of our top priorities.”
While there are scarce issues — if any — on which you can get both Republicans and Democrats to agree these days, high drug prices is one of them. There is bipartisan agreement that something must be done to help Americans get greater access to the medicines they need with prices they can afford. But the political class of lobbyists and corporatists have consistently blocked any meaningful reform.
